RNA NanoBiotics
Developer of RNA-based nanoparticle delivery systems for targeted delivery of therapeutic payloads to cancer cells. Focuses on incorporating nucleic acid therapeutics (RNAi, miRNA), nucleosides, radioisotopes and chemotherapeutics into RNA-based nanoparticles and using aptamer-mediated targeting to improve delivery, solubility of hydrophobic drugs, and enable combination therapy approaches with a view toward clinical translation.
Industries
N/A
Products
RNA nanoparticle delivery platform
A platform for engineering RNA-based nanoparticles that carry and deliver combinations of RNA therapeutics, nucleosides, radioisotopes and chemotherapeutic agents with aptamer-mediated targeting.
RNA nanoparticle delivery platform
A platform for engineering RNA-based nanoparticles that carry and deliver combinations of RNA therapeutics, nucleosides, radioisotopes and chemotherapeutic agents with aptamer-mediated targeting.
Services
Licensing and partnering for technology development
Engagements for investment, licensing or partnership to advance RNA nanoparticle-based delivery technologies toward clinical development.
Licensing and partnering for technology development
Engagements for investment, licensing or partnership to advance RNA nanoparticle-based delivery technologies toward clinical development.
Expertise Areas
- Targeted drug delivery
- RNA therapeutics (RNAi and microRNA)
- Nanobiotechnology
- Aptamer-based targeting
Key Technologies
- RNA nanotechnology
- RNA nanoparticles
- Aptamer-mediated targeting
- RNA interference (RNAi)